These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12642787)

  • 41. Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance.
    Miksztowicz V; Lucero D; Zago V; Cacciagiú L; Lopez G; Gonzalez Ballerga E; Sordá J; Fassio E; Schreier L; Berg G
    Diabetes Metab Res Rev; 2012 Sep; 28(6):535-41. PubMed ID: 22539458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative assessment of the effect of hepatic lipase gene polymorphism on the risk of coronary heart disease.
    Wang H; Jiang M; Qiu J
    Arch Med Res; 2010 Jul; 41(5):383-90. PubMed ID: 20851298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.
    Kobayashi J; Miyashita K; Nakajima K; Mabuchi H
    J Atheroscler Thromb; 2015; 22(10):1001-11. PubMed ID: 26194979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese.
    Tan KC; Shiu SW; Chu BY
    Atherosclerosis; 2001 Jul; 157(1):233-9. PubMed ID: 11427226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fat intake influences the effect of the hepatic lipase C-514T polymorphism on HDL-cholesterol levels in children.
    Riestra P; López-Simón L; Ortega H; Gorgojo L; Martin-Moreno JM; Schoppen S; de Oya M; Garcés C
    Exp Biol Med (Maywood); 2009 Jul; 234(7):744-9. PubMed ID: 19429860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease.
    Hong SH; Song J; Kim JQ
    Clin Biochem; 2000 Jun; 33(4):291-6. PubMed ID: 10936588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
    Sich D; Saïdi Y; Giral P; Lagrost L; Egloff M; Auer C; Gautier V; Turpin G; Beucler I
    Metabolism; 1998 Aug; 47(8):965-73. PubMed ID: 9711993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
    Andersen RV; Wittrup HH; Tybjaerg-Hansen A; Steffensen R; Schnohr P; Nordestgaard BG
    J Am Coll Cardiol; 2003 Jun; 41(11):1972-82. PubMed ID: 12798568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.
    Deeb SS; Zambon A; Carr MC; Ayyobi AF; Brunzell JD
    J Lipid Res; 2003 Jul; 44(7):1279-86. PubMed ID: 12639974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.
    Wang C; Nishijima K; Kitajima S; Niimi M; Yan H; Chen Y; Ning B; Matsuhisa F; Liu E; Zhang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1282-1289. PubMed ID: 28546217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
    Zambon A; Hokanson JE; Brown BG; Brunzell JD
    Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
    Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recent data on hepatic lipase gene. Structure and functions of this enzyme].
    Arca-Sedda Benhizia F; Lagrange D; Griglio S
    Ann Biol Clin (Paris); 1996; 54(3-4):117-30. PubMed ID: 8881357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.
    Isaacs A; Willems SM; Bos D; Dehghan A; Hofman A; Ikram MA; Uitterlinden AG; Oostra BA; Franco OH; Witteman JC; van Duijn CM
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2233-9. PubMed ID: 23766260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.